» Articles » PMID: 20132547

Prosaposin Down-modulation Decreases Metastatic Prostate Cancer Cell Adhesion, Migration, and Invasion

Overview
Journal Mol Cancer
Publisher Biomed Central
Date 2010 Feb 6
PMID 20132547
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Factors responsible for invasive and metastatic progression of prostate cancer (PCa) remain largely unknown. Previously, we reported cloning of prosaposin (PSAP) and its genomic amplification and/or overexpression in several androgen-independent metastatic PCa cell lines and lymph node metastases. PSAP is the lysosomal precursor of saposins, which serve as activators for lysosomal hydrolases involved in the degradation of ceramide (Cer) and other sphingolipids.

Results: Our current data show that, in metastatic PCa cells, stable down-modulation of PSAP by RNA-interference via a lysosomal proteolysis-dependent pathway decreased beta1A-integrin expression, its cell-surface clustering, and adhesion to basement membrane proteins; led to disassembly of focal adhesion complex; and decreased phosphorylative activity of focal adhesion kinase and its downstream adaptor molecule, paxillin. Cathepsin D (CathD) expression and proteolytic activity, migration, and invasion were also significantly decreased in PSAP knock-down cells. Transient-transfection studies with beta1A integrin- or CathD-siRNA oligos confirmed the cause and effect relationship between PSAP and CathD or PSAP and Cer-beta1A integrin, regulating PCa cell migration and invasion.

Conclusion: Our findings suggest that by a coordinated regulation of Cer levels, CathD and beta1A-integrin expression, and attenuation of "inside-out" integrin-signaling pathway, PSAP is involved in PCa invasion and therefore might be used as a molecular target for PCa therapy.

Citing Articles

Intact glycopeptide analysis of human prostate tissue reveals site-specific heterogeneity of protein glycosylation in prostate cancer.

Kapp K, Garcia-Marques F, Totten S, Bermudez A, Tanimoto C, Brooks J Glycobiology. 2025; 35(4).

PMID: 40036572 PMC: 11899575. DOI: 10.1093/glycob/cwaf010.


Role of Prosaposin and Extracellular Sulfatase Sulf-1 Detection in Pleural Effusions as Diagnostic Biomarkers of Malignant Mesothelioma.

Zallocco L, Silvestri R, Ciregia F, Bonotti A, Marino R, Foddis R Biomedicines. 2022; 10(11).

PMID: 36359323 PMC: 9687327. DOI: 10.3390/biomedicines10112803.


Comparative proteomic analysis of silica-induced pulmonary fibrosis in rats based on tandem mass tag (TMT) quantitation technology.

Bo C, Geng X, Zhang J, Sai L, Zhang Y, Yu G PLoS One. 2020; 15(10):e0241310.

PMID: 33119648 PMC: 7595299. DOI: 10.1371/journal.pone.0241310.


Impact of Increased FUT8 Expression on the Extracellular Vesicle Proteome in Prostate Cancer Cells.

Clark D, Schnaubelt M, Hoti N, Hu Y, Zhou Y, Gooya M J Proteome Res. 2020; 19(6):2195-2205.

PMID: 32378902 PMC: 7345075. DOI: 10.1021/acs.jproteome.9b00578.


Putative Biomarkers for Malignant Pleural Mesothelioma Suggested by Proteomic Analysis of Cell Secretome.

Lacerenza S, Ciregia F, Giusti L, Bonotti A, Greco V, Giannaccini G Cancer Genomics Proteomics. 2020; 17(3):225-236.

PMID: 32345664 PMC: 7259891. DOI: 10.21873/cgp.20183.


References
1.
Fornaro M, Tallini G, Bofetiado C, Bosari S, Languino L . Down-regulation of beta 1C integrin, an inhibitor of cell proliferation, in prostate carcinoma. Am J Pathol. 1996; 149(3):765-73. PMC: 1865133. View

2.
Murant S, Handley J, Stower M, Reid N, Cussenot O, Maitland N . Co-ordinated changes in expression of cell adhesion molecules in prostate cancer. Eur J Cancer. 1997; 33(2):263-71. DOI: 10.1016/s0959-8049(96)00418-2. View

3.
Laurent-Matha V, Lucas A, Huttler S, Sandhoff K, Garcia M, Rochefort H . Procathepsin D interacts with prosaposin in cancer cells but its internalization is not mediated by LDL receptor-related protein. Exp Cell Res. 2002; 277(2):210-9. DOI: 10.1006/excr.2002.5556. View

4.
Zipf D, Springer W . Quantification of integrin subunits on human prostatic cell lines--comparison of nontumorigenic and tumorigenic lines. Prostate. 1997; 31(1):1-8. DOI: 10.1002/(sici)1097-0045(19970401)31:1<1::aid-pros1>3.0.co;2-s. View

5.
OBrien J, Carson G, Seo H, Hiraiwa M, Weiler S, Tomich J . Identification of the neurotrophic factor sequence of prosaposin. FASEB J. 1995; 9(8):681-5. DOI: 10.1096/fasebj.9.8.7768361. View